๐Ÿ•ต๏ธ Shuttle Pharmaceuticals Holdings, Inc. ($SHPH)

SEC insider & ownership activity, last 12 months ยท CIK 1757499 ยท every row links its SEC filing

Insider buy value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), Aug 28, 2026.

Insider flow

1 buyer, value withheld pending verification (6 lots) ยท 1 seller, $505K (5 lots)

InsiderBuysBoughtSellsSoldLast
HRT Financial LP6value withheld pending verification 5$505KJul 14, 2026

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Unregistered equity sale (3.02)Sep 9, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Sep 9, 2026 filing โ†—
Shareholder vote (5.07)Sep 9, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Sep 9, 2026 filing โ†—
Other events (8.01)Sep 2, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Sep 2, 2026 filing โ†—
Material agreement (1.01)Aug 31, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 31, 2026 filing โ†—
Delisting notice (3.01)Aug 28, 2026 filing โ†—
Reg FD disclosure (7.01)Aug 28, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 28, 2026 filing โ†—
Reg FD disclosure (7.01)Jun 25, 2026 filing โ†—
Other events (8.01)Jun 25, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 25, 2026 filing โ†—
Material Modifications to Rights of Security Holders (3.03)Jun 10, 2026 filing โ†—
Charter/bylaw changes (5.03)Jun 10, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 10, 2026 filing โ†—
Shareholder vote (5.07)May 21, 2026 filing โ†—
Acquisition or disposition (2.01)May 1, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 1, 2026 filing โ†—
Material agreement (1.01)May 1, 2026 filing โ†—
Acquisition or disposition (2.01)May 1, 2026 filing โ†—
Unregistered equity sale (3.02)May 1, 2026 filing โ†—
Material Modifications to Rights of Security Holders (3.03)May 1, 2026 filing โ†—
Officer/director changes (5.02)May 1, 2026 filing โ†—
Charter/bylaw changes (5.03)May 1, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 1, 2026 filing โ†—
Material agreement (1.01)Apr 30, 2026 filing โ†—
Unregistered equity sale (3.02)Apr 30, 2026 filing โ†—
Reg FD disclosure (7.01)Apr 30, 2026 filing โ†—